Clinicopathologic Analysis of the Impact of CD23 Expression in Plasma Cell Myeloma with t(11;14)(q13;q32)

被引:0
|
作者
Buonaccorsi, J. N. [1 ]
Kroft, S. H. [1 ]
Harrington, A. [1 ]
Van Tuinen, P. [1 ]
Olteanu, H. [1 ]
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1225
引用
收藏
页码:288A / 288A
页数:1
相关论文
共 50 条
  • [21] Genetics of t(11;14)(q13;q32)-negative MCL.
    Wlodarska, Iwona
    Vanhentenrijk, Vera
    Pospisilova, Helena
    Van Roosbroeck, Katrien
    Stul, Michel
    Minnei, Francesca
    Vandenberghe, Peter
    Verhoef, Gregor
    De Wolf-Peeters, Chris
    BLOOD, 2006, 108 (11) : 587A - 587A
  • [22] High incidence of translocations t(11;14) (q13;q32) and t(4;14) (p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau, H
    Li, JY
    Facon, T
    Brigaudeau, C
    Morineau, N
    Maloisel, F
    Rapp, MJ
    Talmant, P
    Trimoreau, F
    Jaccard, A
    Harousseau, JL
    Bataille, R
    BLOOD, 1998, 92 (10) : 716A - 717A
  • [23] Plasma cell myeloma with t(11;14)(q13;q32) displays a distinct pattern of cyclin D1 immunohistochemical staining
    Cook, JR
    Hartke, M
    Pettay, J
    Swain, E
    Hsi, ED
    Tubbs, RR
    MODERN PATHOLOGY, 2005, 18 : 226A - 226A
  • [24] Plasma cell myeloma with t(11;14)(q13;q32) displays a distinct pattern of cyclin D1 immunohistochemical staining
    Cook, JR
    Hartke, M
    Pettay, J
    Swain, E
    Hsi, ED
    Tubbs, RR
    LABORATORY INVESTIGATION, 2005, 85 : 226A - 226A
  • [25] Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants
    Avet-Loiseau, H
    Garand, R
    Lodé, L
    Harousseau, JL
    Bataille, R
    BLOOD, 2003, 101 (04) : 1570 - 1571
  • [26] Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32)
    Kobayashi, H
    Saito, H
    Kitano, K
    Kiyosawa, K
    Gaun, S
    Aoki, K
    Narita, A
    Watanabe, M
    Uchimaru, K
    Motokura, T
    ACTA HAEMATOLOGICA, 1995, 94 (04) : 199 - 203
  • [27] Favorable survival of multiple myeloma patients with t(11;14)(q13;q32) plus normal chromosome 13q.
    Kaufmann, H
    Baldia, C
    Ackermann, J
    Noesslinger, T
    Gisslinger, H
    Jaeger, U
    Sagaster, V
    Seidl, S
    Keck, A
    Ludwig, H
    Simonitsch-Klupp, I
    Zielinski, C
    Drach, J
    BLOOD, 2004, 104 (11) : 942A - 942A
  • [28] Overexpression of cyclin DI in chronic lymphoproliferation with t(11;14)(q13;q32)
    Takahashi, T
    Hayashi, T
    Minami, T
    Adachi, M
    Hinoda, Y
    Imai, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 66 (04) : 521 - 523
  • [29] Improving the accuracy of detection of t(11;14)(q13;q32) and t(14;18)(q32;q21) chromosomal translocations by PCR
    Wickham, CL
    Harries, LW
    Sarsfield, P
    Joyner, MV
    Ellard, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 42 - 42
  • [30] Extramedullary plasmacytoma with a t(11;14)(q13;q32) and aggressive clinical course
    Parkins, Elizabeth
    Boll, Maayke
    O'Connor, Sheila J. M.
    Rawstron, Andy C.
    Owen, Roger G.
    LEUKEMIA & LYMPHOMA, 2010, 51 (07) : 1360 - 1362